Althea is a fully integrated contract development and manufacturing organization (CDMO) committed to the success of our clients for process development, drug substance manufacturing and drug product manufacturing. In a single location, Althea has the capacity to support early-stage clinical requirements through commercial manufacturing. Althea is a leading expert in executing drug formulation and aseptic fill finish for vials and syringes. We pride ourselves on being the manufacturing partner that delivers the relentless dedication and support our clients need. Learn more at www.AltheaCMO.com
$23M sweet spot round size
1998
$23M
from 1 investors over 1 rounds
Althea, CMO raised $23M on February 10, 2007
Investors: Telegraph Hill Partners